MyndTec, Inc. (MYTC) AI Stock Analysis

• Market Cap: N/A
• Dividend Yield: N/A
• Average Volume (3M): 250.00
• Price to Earnings (P/E): ―
• Beta (1Y): -5.19
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: CA
• Employees: 7
• Sector: Healthcare
• Sector Strength: 69
• Industry: Medical - Devices
• EPS (TTM): N/A
• Shares Outstanding: 25,089,895
• 10 Day Avg. Volume: 0
• 30 Day Avg. Volume: 250
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 25.16
• Price to Cash Flow (P/CF): -4.50
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

MyndTec, Inc. faces significant financial challenges, with substantial risks due to negative equity and persistent losses, which weigh heavily on its overall score. Despite some positive momentum from a recent private placement initiative, the technical indicators suggest a bearish trend, and the absence of key valuation metrics further limits investor appeal. Collectively, these factors contribute to a low overall score, indicating caution for potential investors.

MyndTec, Inc. Business Overview & Revenue Model

Company Description

MyndTec, Inc. (MYTC) is a medical technology company specializing in the development and commercialization of innovative neuro-rehabilitation therapies. The company operates within the healthcare and biotechnology sectors, focusing on creating products that aid in the recovery of individuals with neurological impairments, particularly those who have suffered from strokes or spinal cord injuries. MyndTec's core product, MyndMove, is a non-invasive therapy system designed to improve voluntary motor function through functional electrical stimulation.

How the Company Makes Money

MyndTec makes money primarily through the sale and distribution of its flagship product, MyndMove, to healthcare providers, rehabilitation centers, and hospitals. The company generates revenue by offering MyndMove as a service, where customers pay for the device as well as the ongoing treatment sessions provided to patients. Additionally, MyndTec may earn income from training healthcare professionals on the use of their systems and through service contracts for maintenance and support. Strategic partnerships with medical institutions and research organizations can also contribute to revenue by expanding the reach and adoption of MyndTec's technologies.

MyndTec, Inc. Financial Statement Overview

Summary

Overall, MyndTec, Inc. is facing substantial financial challenges. The company struggles with declining revenue, persistent losses, and negative cash flows, reflecting in weak profitability and operational efficiency. The negative equity position and high leverage pose significant financial risks, necessitating strategic actions to stabilize the company's financial health.

Income Statement

MyndTec, Inc. shows significant challenges in its income statement. The revenue has declined over the years, with a notable drop from the previous periods. The company consistently reports negative net income, leading to negative net profit margins. The gross profit margin is minimal, and EBIT and EBITDA margins are negative, indicating operational inefficiencies and a struggle to cover operating expenses.

Balance Sheet

The balance sheet reflects a concerning financial position with negative stockholders' equity, indicating that liabilities exceed assets. The debt-to-equity ratio is not calculable due to negative equity, highlighting potential solvency issues. The equity ratio is negative, which further underscores the financial instability. The company is highly leveraged, increasing financial risk.

Cash Flow

MyndTec, Inc.'s cash flow statement reveals persistent negative operating and free cash flows, suggesting an inability to generate cash from operations. The operating cash flow to net income ratio is negative, indicating more cash is flowing out than income generated. Despite this, the company has been able to secure financing, albeit reflecting dependency on external funding.

Breakdown
Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
137.31K	255.80K	605.57K	162.63K
	Gross Profit
54.90K	67.44K	354.62K	67.04K
	EBIT
-1.59M	-2.02M	-2.74M	-1.62M
	EBITDA
-1.58M	-1.88M	-2.62M	-1.15M
	Net Income Common Stockholders
-1.72M	-2.25M	-3.34M	-1.81M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
187.41K	68.62K	377.06K	668.58K
	Total Assets
554.85K	642.57K	3.82M	1.65M
	Total Debt
455.51K	734.19K	2.08M	1.71M
	Net Debt
268.10K	665.57K	1.70M	1.04M
	Total Liabilities
1.47M	1.57M	7.37M	3.48M
	Stockholders Equity
-919.78K	-925.34K	-3.54M	-1.83M
Cash Flow		Free Cash Flow
-976.91K	-2.39M	-1.50M	-1.41M
	Operating Cash Flow
-976.91K	-2.34M	-1.44M	-1.40M
	Investing Cash Flow
0.00	-42.01K	-64.44K	-19.40K
	Financing Cash Flow
1.10M	2.08M	1.21M	1.67M

MyndTec, Inc. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.08
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:MYTC, the sentiment is Negative. The current price of 0.08 is below the 20-day moving average (MA) of 0.10, below the 50-day MA of 0.13, and below the 200-day MA of 0.10, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 2.92 is Positive, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:MYTC.

MyndTec, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51 Neutral	$5.31B	3.39	-40.42%	2.90%	18.11%	2.25%
MYTC	33 Underperform		―	110.13%	―	―	―

MyndTec, Inc. Corporate Events

MyndTec Inc. Launches $1.5 Million Private Placement to Boost Corporate Development

MyndTec Inc. has announced a non-brokered private placement offering of up to 7,500,000 units at $0.20 per unit to raise $1,500,000. The proceeds will be used for general corporate purposes, including working capital and development of machine learning models. The offering is subject to necessary approvals and will be available in Canada, the United States, and other jurisdictions under applicable laws. This initiative aims to strengthen MyndTec’s financial position and support its corporate development and marketing strategies, potentially enhancing its industry standing and operational capacity.

MyndTec Completes Third Tranche of Private Placement

MyndTec Inc. has successfully completed the third tranche of its non-brokered private placement, raising $193,880, bringing the total proceeds from the offering to $472,042.25. The funds will be used for general corporate purposes, including working capital and sales and marketing. The units issued, including common shares and warrants, are subject to statutory hold periods and transfer restrictions. The participation of related parties in this private placement was exempt from certain regulatory requirements, and the completion of the transaction is pending final acceptance by the Canadian Securities Exchange.

MyndTec Partners with Albany Medical for Pain Tech

MyndTec Inc. has secured exclusive rights to a machine learning-based technology from Albany Medical College aimed at enhancing spinal cord stimulation for pain management. This agreement could revolutionize the treatment of chronic pain by offering non-pharmacological, data-driven solutions. The technology promises improved patient outcomes and increased efficiency for healthcare providers.